本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

NLS Pharmaceutics Ltd.

1.63
-0.0099-0.60%
盤後1.61-0.0201-1.23%16:08 EDT
成交量:1.32萬
成交額:2.16萬
市值:586.44萬
市盈率:-0.25
高:1.75
開:1.72
低:1.58
收:1.64
資料載入中...
2022/02/24

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

SEC問詢函

CORRESP [Cover] - Correspondence
2022/01/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/04

SEC問詢函

CORRESP [Cover] - Correspondence
2021/12/20

招股説明書

F-1 - Registration statement for certain foreign private issuers
2021/11/01

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/11/01

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/22

招股説明書

F-1 - Registration statement for certain foreign private issuers
2021/10/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/14

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/25

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/25

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/20

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/11/19

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/17

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/11/13

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers